Investigators report on the development of imaging-based biomarkers that will have an impact on diagnosis before the Alzheimer's disease process is set in motion.
Scientists have taken a step toward developing a blood test for Alzheimer's, finding a group of markers that hold up in statistical analyses in three independent groups of patients.
Men may be at higher risk of experiencing mild cognitive impairment (MCI), or the stage of mild memory loss that...
